<bill session="115" type="h" number="5590" updated="2019-04-18T16:22:46Z">
  <state datetime="2018-06-19T15:33:55-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2018-06-19T15:33:55-04:00"/>
  </status>
  <introduced datetime="2018-04-24"/>
  <titles>
    <title type="official" as="introduced">To require the Secretary of Health and Human Services to provide for an action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to medication-assisted treatment, and for other purposes.</title>
    <title type="short" as="passed house">Opioid Addiction Action Plan Act</title>
    <title type="short" as="passed house">Opioid Addiction Action Plan Act</title>
    <title type="short" as="reported to house">Opioid Addiction Action Plan Act</title>
    <title type="short" as="reported to house">Opioid Addiction Action Plan Act</title>
    <title type="short" as="introduced">Opioid Addiction Action Plan Act</title>
    <title type="short" as="introduced">Opioid Addiction Action Plan Act</title>
    <title type="display">Opioid Addiction Action Plan Act</title>
  </titles>
  <sponsor bioguide_id="K000378"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2018-05-17"/>
    <cosponsor bioguide_id="C001067" joined="2018-04-24"/>
    <cosponsor bioguide_id="D000096" joined="2018-04-24"/>
    <cosponsor bioguide_id="L000585" joined="2018-04-24"/>
    <cosponsor bioguide_id="M001201" joined="2018-06-08"/>
    <cosponsor bioguide_id="W000791" joined="2018-05-25"/>
  </cosponsors>
  <actions>
    <action datetime="2018-04-24">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-04-24" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-04-24">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-05-17">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-17" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </calendar>
    <action datetime="2018-06-12">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-746, Part I.</text>
    </action>
    <action datetime="2018-06-12">
      <text>Committee on Ways and Means discharged.</text>
    </action>
    <calendar datetime="2018-06-12" calendar="Union" number="580">
      <text>Placed on the Union Calendar, Calendar No. 580.</text>
    </calendar>
    <action datetime="2018-06-19T15:30:20-04:00">
      <text>Mr. Guthrie moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2018-06-19T15:30:38-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5247-5249" label="consideration"/>
    </action>
    <action datetime="2018-06-19T15:30:42-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 5590.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2018-06-19T15:33:55-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5247-5248" label="text"/>
    </vote>
    <action datetime="2018-06-19T15:34:04-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2018-06-20">
      <text>Received in the Senate and Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Discharged, Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="6"/>
    <bill type="s" session="115" relation="unknown" number="2769"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health information and medical records"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medicaid"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
    <term name="Mental health"/>
    <term name="Public participation and lobbying"/>
    <term name="Rural conditions and development"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-19T09:05:46Z" status="Passed House amended">Opioid Addiction Action Plan Act

(Sec. 2) This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to develop an action plan to provide recommendations on changes to the Medicare and Medicaid programs to enhance: (1) the treatment and prevention of opioid addiction, and (2) the coverage and payment of medication-assisted treatment for opioid addiction. The CMS must convene a stakeholder meeting to solicit public comment on the action plan.

 The CMS must also publish a report that includes an evaluation of price trends for opioid overdose-reversal drugs (e.g., naloxone) and recommendations on ways to lower consumer prices for such drugs.</summary>
  <committee-reports>
    <report>H. Rept. 115-746</report>
  </committee-reports>
</bill>
